发明申请
US20050239789A1 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a] indoles
失效
抗肥胖症1,2,3,4,10,10a-六氢吡嗪并[1,2-a]吲哚
![Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a] indoles](/docs/US/2005-10-27/US20050239789A1/abs.jpg.600x600.jpg)
- 专利标题： Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a] indoles
- 专利标题（中）： 抗肥胖症1,2,3,4,10,10a-六氢吡嗪并[1,2-a]吲哚
-
申请号： US11169079申请日： 2005-06-28
-
公开(公告)号： US20050239789A1公开(公告)日： 2005-10-27
- 发明人: Jonathan Bentley , Paul Hebeisen , Patrizio Mattei , Marc Muller , Hans Richter , Stephan Roever , Sven Taylor
- 申请人： Jonathan Bentley , Paul Hebeisen , Patrizio Mattei , Marc Muller , Hans Richter , Stephan Roever , Sven Taylor
- 优先权： EP00116517.4 20000731
- 主分类号： A61K31/337
- IPC分类号： A61K31/337 ; A61K31/4985 ; A61K45/00 ; A61P1/00 ; A61P3/04 ; A61P3/10 ; A61P7/02 ; A61P9/00 ; A61P11/00 ; A61P13/00 ; A61P15/00 ; A61P25/00 ; A61P25/06 ; A61P25/08 ; A61P25/18 ; A61P25/20 ; A61P25/22 ; A61P25/24 ; A61P25/28 ; A61P25/30 ; A61P25/32 ; C07D487/04 ; A61K31/498
![Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a] indoles](/abs-image/US/2005/10/27/US20050239789A1/abs.jpg.150x150.jpg)
摘要：
The present invention is directed to 1,2,3,4,10,10a,-hexahydropyrazino[1,2-a]indole derivatives as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R8 have the significance given in claim 1 be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea.
公开/授权文献
- US07253281B2 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles 公开/授权日：2007-08-07
信息查询
